Lambda Therapeutic Research Limited is a leading Multinational Clinical Research Organisation (CRO) providing full drug development services. Headquartered in Ahmedabad, India, we have facilities and operations in Mumbai (India), Toronto (Canada), Warsaw (Poland), London (UK) and USA.

Lambda's core strength

• More than 45 years of service to the biopharmaceutical and generic industry
• Capabilities to offer a complete spectrum of Early Clinical development services like Phase I, First-in-Man, BA/BE, DDI studies as well as late Phase II - IV studies, Bioanalytical, Pharmacovigilance, Medical Imaging services as a package or a stand-alone service
• We deliver custom made solutions for special population studies
• More than 4,500 clinical studies completed globally
• More than 100,000 active study participants in database globally
• More than 600 validated LC/MS - MS assays available globally
• Over 50 successful regulatory audits and inspections globally
• Applying innovative technologies, therapeutic expertise and a commitment to quality in order to help clients develop products safely, effectively and quickly
• Management team comprising highly qualified & experienced industry leaders

State-of-the-art Infrastructure

• More than 640+ clinical beds globally
• 16 bedded Phase I unit in Ahmedabad, India
• 12 bedded Phase I unit in Toronto, Canada
• 6 bedded Phase I unit in Warsaw, Poland
• More than 40 LC-MS/MS systems
• CAP/NGSP accredited Clinical Laboratory, Molecular and Microbiological laboratory
• Conduct QT studies with replicate ECGs and ECG Core Laboratory
• Low temperature storage (2-8 °C, -20 °C and -80 °C) controlled storage facility to store over 4.0 million samples
• Adverse Event Safety Database
• Clinical Data Management System: Clintrial™ 4.5